Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer

NCT02716961 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

208

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Gemcitabine and Cisplatin Chemotherapy
Epirubicin Instillation
Recurrence
Prognosis

Interventions

DRUG: Gemcitabine, cisplatin

Sponsor

The First Affiliated Hospital with Nanjing Medical University